CA983932A - Indole derivatives - Google Patents

Indole derivatives

Info

Publication number
CA983932A
CA983932A CA152,944A CA152944A CA983932A CA 983932 A CA983932 A CA 983932A CA 152944 A CA152944 A CA 152944A CA 983932 A CA983932 A CA 983932A
Authority
CA
Canada
Prior art keywords
indole derivatives
indole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA152,944A
Other languages
English (en)
Other versions
CA152944S (en
Inventor
George R. Birchall
Walter Hepworth
Stephen C. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of CA983932A publication Critical patent/CA983932A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
CA152,944A 1971-11-03 1972-09-29 Indole derivatives Expired CA983932A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1811672A GB1356834A (en) 1971-11-03 1971-11-03 Indole derivatives
GB1811672 1972-04-19
GB3076772 1972-06-30

Publications (1)

Publication Number Publication Date
CA983932A true CA983932A (en) 1976-02-17

Family

ID=27257588

Family Applications (1)

Application Number Title Priority Date Filing Date
CA152,944A Expired CA983932A (en) 1971-11-03 1972-09-29 Indole derivatives

Country Status (17)

Country Link
US (1) US3884919A (fr)
JP (1) JPS4856667A (fr)
AR (3) AR198064A1 (fr)
BE (1) BE790679A (fr)
CA (1) CA983932A (fr)
CH (1) CH577499A5 (fr)
DD (1) DD105611A5 (fr)
DE (1) DE2253927A1 (fr)
EG (1) EG11358A (fr)
ES (2) ES408226A1 (fr)
FR (1) FR2158464B1 (fr)
GB (1) GB1356834A (fr)
HU (1) HU169711B (fr)
IE (1) IE37998B1 (fr)
IL (1) IL40521A (fr)
NL (1) NL7214807A (fr)
SE (1) SE384856B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) * 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
FR2421900A1 (fr) * 1977-03-17 1979-11-02 Sauba Lab Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines
US4459227A (en) * 1981-03-02 1984-07-10 Duke University Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones
CZ288955B6 (cs) * 1994-02-23 2001-10-17 Pfizer Inc. Substituované chinazolinové deriváty, jejich pouľití a farmaceutické prostředky na jejich bázi
US6252084B1 (en) * 1994-03-15 2001-06-26 Eli Lilly And Company 1H-indole-3-acetamide sPLA2 inhibitors
CA2322162A1 (fr) * 1998-02-25 1999-09-02 Genetics Institute, Llc Inhibiteurs d'enzymes phospholipases
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
SE0200356D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200411D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
TW200307542A (en) * 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301010D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SE0301009D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
EP1471057B1 (fr) 2003-04-25 2006-01-18 Actimis Pharmaceuticals, Inc. Derivés de l'acid pyrimidinylacétique pour le traitment des maladies associées au CRTH2
ATE372324T1 (de) * 2003-04-30 2007-09-15 Inst For Pharm Discovery Inc Substituierte heteroarylverbindungen als inhibitoren von proteintyrosinphosphatasen
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
ZA200605387B (en) 2004-01-31 2008-05-28 Actimis Pharmaceuticals Inc Imidazo[1.2-c]pyrimidinylacetic acid derivatives
GB0415320D0 (en) 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
GB0418830D0 (en) 2004-08-24 2004-09-22 Astrazeneca Ab Novel compounds
SI1817282T1 (sl) 2004-11-23 2011-10-28 Astrazeneca Ab Derivati fenoksiocetne kisline, uporabni za zdravljenje respiratornih bolezni
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
US8148572B2 (en) 2005-10-06 2012-04-03 Astrazeneca Ab Compounds
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
CN102558021A (zh) 2006-05-26 2012-07-11 阿斯利康(瑞典)有限公司 联芳基或芳基-杂芳基取代的吲哚类化合物
PT2046740E (pt) 2006-07-22 2012-08-28 Oxagen Ltd Compostos com atividade antagonista do crth2
UA100983C2 (ru) 2007-07-05 2013-02-25 Астразенека Аб Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
PL2205569T3 (pl) 2007-09-25 2012-08-31 Actimis Pharmaceuticals Inc Alkilotiopirymidyny jako antagoniści crth2
RU2491279C2 (ru) 2007-09-25 2013-08-27 Актимис Фармасьютикалз, Инк. 2-s-бензилзамещенные пиримидины в качестве антагонистов crth2
MX2010007833A (es) 2008-01-18 2010-08-11 Oxagen Ltd Compuestos que tienen actividad antagonista de crth2.
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
JP2011509991A (ja) 2008-01-22 2011-03-31 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
EP2265581A1 (fr) 2008-01-22 2010-12-29 Oxagen Limited Composés présentant une activité antagoniste du récepteur crth2
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
MX2021003819A (es) * 2018-10-05 2021-06-23 Vertex Pharma Moduladores de alfa-1 antitripsina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (fr) * 1963-06-06
US3679692A (en) * 1969-10-01 1972-07-25 Mead Johnson & Co Iminomethylindolines

Also Published As

Publication number Publication date
IE37998L (en) 1973-05-03
AR203627A1 (es) 1975-09-30
CH577499A5 (fr) 1976-07-15
EG11358A (en) 1977-02-28
AR203626A1 (es) 1975-09-30
FR2158464A1 (fr) 1973-06-15
DE2253927A1 (de) 1973-05-10
JPS4856667A (fr) 1973-08-09
DD105611A5 (fr) 1974-05-05
ES408226A1 (es) 1976-02-01
IE37998B1 (en) 1977-12-07
IL40521A0 (en) 1972-12-29
BE790679A (fr) 1973-04-27
SE384856B (sv) 1976-05-24
AR198064A1 (es) 1974-05-31
HU169711B (fr) 1977-02-28
NL7214807A (fr) 1973-05-07
IL40521A (en) 1975-06-25
US3884919A (en) 1975-05-20
ES437311A1 (es) 1977-04-01
FR2158464B1 (fr) 1976-07-02
GB1356834A (en) 1974-06-19

Similar Documents

Publication Publication Date Title
CA1006875A (en) Indole derivatives
CA983932A (en) Indole derivatives
AU468250B2 (en) 3-nitropyrazole derivatives
AU462723B2 (en) 2-nitro-5-imidazolyaldehyde derivatives
CA1012150A (en) Indole derivatives
AU461957B2 (en) Lumilysergol derivatives
CA1017335A (en) Triazolyl-ethenyl-phenylene derivatives
AU463679B2 (en) Dibenzocycloheptadioxolan derivatives
AU472069B2 (en) Dibenzoxirenazepine derivatives
AU470552B2 (en) Aminocephalosporin derivatives
GB1405800A (en) Indole derivatives
CA882140A (en) Indole derivatives
AU438840B2 (en) Indole derivatives
AU464145B2 (en) Indole derivatives
CA861515A (en) Indole derivatives
CA876724A (en) Indole derivatives
CA878514A (en) Indole derivatives
CA973882A (en) Indoles
CA866825A (en) 2-benzoyl-3-(2-tertiaryamino-ethoxy)-indole derivatives
AU2912871A (en) Indole derivatives
CA877321A (en) Ndole derivatives
CA882717A (en) Indole alkaloid derivatives
AU475691B2 (en) 7-amino-indazole derivatives
AU458249B2 (en) Tropan-3-ol derivatives
AU454731B2 (en) Pyrazinylurea derivatives